Status:
WITHDRAWN
Efficacy and Safety of Mucoadhesive Sustained Release, Mucodentol, in Comparison With Hydroxychloroquine to Prevent COVID-19
Lead Sponsor:
Baqiyatallah Medical Sciences University
Conditions:
COVID-19
Eligibility:
All Genders
18+ years
Phase:
NA
Brief Summary
180 people from the medical staff and high-risk people in Baqiyatallah Hospital, who are in close contact with patients, will enter the study. Participants will be divided into two intervention groups...
Eligibility Criteria
Inclusion
- Negative PCR testing through throat swabs
- Signing Conscious Consent
Exclusion
- History of ocular complications and visual disturbances
- Sensitivity to plant compounds in the product
Key Trial Info
Start Date :
August 12 2020
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
September 21 2020
Estimated Enrollment :
Patients enrolled
Trial Details
Trial ID
NCT04466280
Start Date
August 12 2020
End Date
September 21 2020
Last Update
August 3 2022
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Mohammad Sadegh Bagheri Baghdasht
Tehran, Iran, 0